SCHEMBL7666457

SCHEMBL7666457

CC(=O)Nc1cccc(C[O])c1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
HSD17B10 Q99714 2/20 0.59
CYP1A2 P05177 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
RAB9A P51151 2/20 0.59
POLB P06746 1/20 0.59
NR4A1 P22736 1/20 0.59
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
TSHR P16473 1/20 0.56
AOC3 Q16853 1/20 0.54
NAPRT Q6XQN6 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MAPT P10636 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.51
NLRP3 Q96P20 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1548607 0.85 ALDH1A1 (0.59) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A
SCHEMBL1817688 0.85 RAB9A (0.64) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A
SCHEMBL840217 0.85 ALDH1A1 (0.59) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A
SCHEMBL27614147 0.84 ALDH1A1 (0.58) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A
SCHEMBL1818695 0.84 NPSR1 (0.61) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A
SCHEMBL12615067 0.84 ALDH1A1 (0.58) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A
SCHEMBL1742555 0.84 ALDH1A1 (0.58) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A
SCHEMBL2545099 0.84 ALDH1A1 (0.61) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A
SCHEMBL10391003 0.84 ALDH1A1 (0.58) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A
SCHEMBL8868314 0.83 AOC3 (0.56) ALDH1A1HSD17B10CYP1A2NPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed